Molecular Biometrics’ research and development mission is to determine the underlying effect of health conditions on the metabolism of biological systems. New and innovative technologies are developed in order to monitor and determine these metabolic changes through non-invasive analysis of biological fluids. MB’s R&D facilities are located in Montreal, Canada and New Haven, CT.
Biospectroscopy Based Metabolomics
Molecular Biometrics refers to its novel technology platform as “Biospectroscopy-based Metabolomics”. This platform represents the confluence of two scientific disciplines: Biospectroscopy, an optical-based analytical technology that performs simultaneous measurement of multiple biomarkers and Metabolomics, the assessment of small molecule biomarkers that represent the status of cellular function in health and disease.
Molecular Biometrics’ primary instrumentation candidate for metabolomic analysis is based on Near Infrared (NIR) spectroscopy. Using NIR spectroscopy, metabolomic profiles of target biological fluids are measured and quantified using proprietary bioinformatics and chemometrics.